July 24, 2020 at 08:38PM FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL

FDA approves first cell-based gene therapy to treat adult patients with MCL who have not responded to or who have relapsed following other kinds of treatment.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32SqxY0